Lindsay Dawn Green, SLP | |
444 Hospital Way, Pocatello, ID 83201-2745 | |
(208) 269-1200 | |
Not Available |
Full Name | Lindsay Dawn Green |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 444 Hospital Way, Pocatello, Idaho |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316423049 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (Idaho) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lindsay Dawn Green, SLP 1940 S Bonito Way Ste 190, Meridian, ID 83642-5618 Ph: (208) 287-9420 | Lindsay Dawn Green, SLP 444 Hospital Way, Pocatello, ID 83201-2745 Ph: (208) 269-1200 |
News Archive
The New York Times explores how intra-GOP allegiances to the business community are changing. Meanwhile, AARP acknowleges that adjustments must be made, but argues against cutting back entitlements. Also in the news, the director of the National Institutes of Health expresses his wariness about the impact sequestration could have on biomedical research.
Open a child's lunch box and you're likely to find that the lunches and snacks inside fall short of federal guidelines. Those are the findings of a study conducted by researchers at the Friedman School of Nutrition Science and Policy at Tufts University and in the Department of Public Health and Community Medicine at Tufts University School of Medicine.
According to a new survey the use of illicit drugs among teenagers has dropped for the third year in a row.
On March 20, Andrew Gaumer celebrated the 10th anniversary of his life-saving heart and double-lung transplant. On Mother's Day, his wife, Andrea, gave birth to their first child, a baby boy named Jude. And on June 21, Andrew will celebrate his first Father's Day - a milestone he once feared he would never see.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, announced on December 13 the initiation of the regulatory process for a Glaucoma Phase II clinical study in Israel. Leading Medical Centers in Israel will enroll 44 patients with Ocular Hypertension or Glaucoma for the first segment of the trial, who will be treated for 16 weeks with CF101 or placebo.
› Verified 8 days ago
Mrs. Molly Lee Hill, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 611 Wilson Ave Ste 6c, Pocatello, ID 83201 Phone: 208-530-0872 | |
Beth Agres, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1001 N 7th Ave, Pocatello, ID 83201 Phone: 208-239-1490 | |
Kami Anne Westover, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1110 Call Creek Dr Ste 4b, Pocatello, ID 83201 Phone: 208-233-4660 Fax: 208-233-4262 | |
Cheryl Zaremba, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 896 Lucille Ave, Pocatello, ID 83201 Phone: 208-234-7302 | |
Mr. James Ellis Williams Ii, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 527 Memorial Dr, Pocatello, ID 83201 Phone: 801-419-8096 | |
Mrs. Heather L. Rogers, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1110 Call Creek Dr Ste 7, Pocatello, ID 83201 Phone: 208-233-4660 Fax: 208-233-4262 | |
Amanda Taylor, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1071 Renee Ave, Pocatello, ID 83201 Phone: 208-233-1411 |